(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CELLTRION CONNECT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CELLTRION CONNECT

ST13

US500000079305125

Class

44

Filing

79305125

Registration

6726756

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

10/21/2023

Trademark type

Word

Nice classes

44

Filing date

01/18/2021

Registration date

05/24/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/24/2022

Last transaction

05/24/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

KR

Examiner

GORAN, BRADLEY

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Celltrion Holdings Co.,Ltd.
CELLTRION, INC.

Representatives

Kisuk Lee Harness, Dickey & Pierce, PLC

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Healthcare; health counselling; medical and health care services; medical information services provided via the internet; Information services relating to medical productsproviding information concerning the proper use of medical treatment apparatus and instruments for biopharmaceutical use; Providing consultancy and information services in the field of biopharmaceutical products; Providing consultancy and information services in the field of pharmaceutical products; Providing consultancy and information services provided via the internet in the field of pharmaceutical products; providing consultancy in the field of pharmaceuticals; providing consultancy in the field of medical products in the nature of diagnostic medical testing; medical consultancy for selecting appropriate medicines; providing information in the field of medicine; advisory services relating to pharmaceutical products; advisory services relating to health care; patient support services for disease diagnosis and treatment in the field of autoimmune disease; patient support services in the field of medical autoimmune disease treatment

Publications

History of USPTO decisions and trademark events.

40 publications found

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

10/21/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/02/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/02/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/08/2022

FIMP

FINAL DISPOSITION PROCESSED

09/08/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/24/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/24/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/24/2022

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

04/10/2022

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

12/29/2021

GPNX

NOTIFICATION PROCESSED BY IB

12/06/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/30/2021

PUBO

PUBLISHED FOR OPPOSITION

11/30/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/17/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/17/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/10/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/28/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

10/28/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/28/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

10/28/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/28/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/16/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/16/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/16/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/16/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/16/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/16/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/16/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/16/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/09/2021

CHLD

CHANGE OF OWNER RECEIVED FROM IB

06/12/2021

RFNT

REFUSAL PROCESSED BY IB

04/05/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/18/2021

RFRR

REFUSAL PROCESSED BY MPU

03/17/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/17/2021

CNRT

NON-FINAL ACTION WRITTEN

03/16/2021

DOCK

ASSIGNED TO EXAMINER

03/16/2021

MAFR

APPLICATION FILING RECEIPT MAILED

03/05/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/01/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/25/2021

Continuous trademark protection

Get notified about every new filing that threatens CELLTRION CONNECT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.